The effects of tectochrysin on prostate cancer cells apoptosis and its mechanism

doi:10.12047/j.cjap.5754.2019.059

Abstract

Abstract: Objective: To investigate the effects of tectochrysin on prostate cancer cell line 22Rv.1 and reveal its molecular mechanism. Methods: Tectochrysin at the concentrations of 0～20 μg/ml was applied to 22Rv.1 cells and normal prostate cell RWPE-1. The proliferation activity of the cells was detected by MTS assay. Flow cytometry and hoechst 33342 staining were used to analyze the effects of drugs on cell apoptosis, death, cell cycle and nuclear type changes. LDH release test was used to analyze the cytotoxicity of the drug to 22Rv.1 cells. QPCR and Western blot were used to analyze the effects of the drug on the expressions of genes in 22Rv.1 cells. Finally, the tumor inhibited effect of the drug on the bearing tumor BALB/c mice were confirmed though anti-tumor experiment. Results: Tectochrysin could significantly inhibit the proliferation activity of 22Rv.1 cells and induced their apoptosis, and promoted the expressions of genes dr4, dr5, trail, p53, caspase-3, caspase-8, caspase-9, bid, bax and foxo3, inhibited the expressions of anti-apoptotic genes akt, pi3k and bcl-2. Conclusion: Tectochrysin can induce prostate cancer cells apoptosis through affecting TRAIL and PI3K/AKT signaling pathways, and has anti-prostate cancer effect.

Key words: tectochrysin, prostate cancer cell line 22Rv.1, TRAIL signal pathway, PI3K/AKT signal pathway, cell apoptosis

WANG Yu, KE Rui-jun, JIANG Pan-ruo, YING Jia-hao, LOU En-zhe, CHEN Jia-yu. The effects of tectochrysin on prostate cancer cells apoptosis and its mechanism[J]. CJAP, 2019, 35(3): 283-288.

References

[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(1): 7-30.
[2] Lv H, Liu Q, Wen Z, et al. Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK/GSK3beta-Nrf2 signal axis[J]. Redox Biol, 2017, 12: 311-324.
[3] 王海华, 曾瑾, 王海珍, 等. 蜂胶总黄酮对慢性心力衰竭大鼠心肌细胞凋亡的影响及其机制[J]. 中国应用生理学杂志, 2015, 31(3): 201-206.
[4] Mozaffarian D, Wu J. Flavonoids, dairy foods, and cardiovascular and metabolic health: A review of emerging biologic pathways[J]. Circ Res, 2018, 122(2): 369-384.
[5] Oh SB, Hwang CJ, Song SY, et al. Anti-cancer effect of tectochrysin in NSCLC cells through overexpression of death receptor and inactivation of STAT3 [J]. Cancer Lett, 2014, 353(1): 95-103.
[6] Park MH, Hong JE, Park ES, et al. Anticancer effect of tectochrysin in colon cancer cell via suppression of NF-kappaB activity and enhancement of death receptor expression[J]. Mol Cancer, 2015, 14: 124.
[7] Li X, Wang X, Zhang J, et al. Hollow boron nitride nanospheres as boron reservoir for prostate cancer treatment[J]. Nat Commun, 2017, 8: 13936.
[8] 金鑫, 孙盼盼, 洪云, 等. 葛根素对人非小细胞肺癌A549细胞凋亡的作用[J]. 中国应用生理学杂志, 2017, 33(5): 466-469.
[9] Henry CM, Martin SJ. Caspase-8 acts in a non-enzymatic role as a scaffold for assembly of a pro-inflammatory “FADDosome” complex upon TRAIL stimulation[J]. Molecular Cell, 2017, 65(4): 715-729.
[10]von Karstedt S, Montinaro A, Walczak H. Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy[J]. Nat Rev Cancer, 2017, 17(6): 352-366.
[11]Li N, Xue W, Yuan H, et al. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis [J]. J Clin Invest, 2017, 127(4): 1284-1302.
[12]Marques RB, Aghai A, de Ridder C, et al. High efficacy of combination therapy using PI3K/AKT inhibitors with androgen deprivation in prostate cancer preclinical models[J]. Eur Urol, 2015, 67(6): 1177-1185.
[13]Popolo A, Pinto A, Daglia M, et al. Two likely targets for the anti-cancer effect of indole derivatives from cruciferous vegetables: PI3K/Akt/mTOR signalling pathway and the aryl hydrocarbon receptor[J]. Semin Cancer Biol, 2017, 46: 132 -137.
[14]Mehta A, Zhao JL, Sinha N, et al. The microRNA-132 and microRNA-212 cluster regulates hematopoietic stem cell maintenance and survival with age by buffering FOXO3 expression[J]. Immunity, 2015, 42(6): 1021-1032.
[15]Chung YM, Park SH, Tsai WB, et al. FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage[J]. Nat Commun, 2012, 3(3): 1000.
[16]Ou HL, Schumacher B. DNA damage responses and p53 in the aging process[J]. Blood, 2018, 131(5): 488-495.
[17]Bieging KT, Mello SS, Attardi LD. Unravelling mechanisms of p53-mediated tumour suppression[J]. Nat Rev Cancer, 2014, 14(5): 359-370.